Search

Your search keyword '"Suryapranata, H."' showing total 1,391 results

Search Constraints

Start Over You searched for: Author "Suryapranata, H." Remove constraint Author: "Suryapranata, H."
1,391 results on '"Suryapranata, H."'

Search Results

2. Gender differences with short-term vs 12 months dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-years follow-up results of the REDUCE trial

5. The mega COMBO collaboration: An individual patient data pooled analysis of patients undergoing PCI with COMBO stent.

6. Gender Difference in the Effects of COVID-19 Pandemic on Mechanical Reperfusion and 30-Day Mortality for STEMI: Results of the ISACS-STEMI COVID-19 Registry.

7. Age-Related Effects of COVID-19 Pandemic on Mechanical Reperfusion and 30-Day Mortality for STEMI: Results of the ISACS-STEMI COVID-19 Registry.

8. Impact of renal failure and high-platelet reactivity on major cardiovascular ischemic events among patients with acute coronary syndrome receiving dual antiplatelet therapy with ticagrelor

13. COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction

18. COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction

19. Versatile Aspects of Cardiac Troponin Assessment: Innovative Clinical Settings, Coronary Sinus Sampling, and Qualitative Laboratory Analyses

20. Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

21. Final benefit of primary percutaneous coronary intervention for ST-elevation myocardial infarction in older patients:long-term results of a randomised trial

23. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

26. Impact of age on the comparison between short-term vs 12-month dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-Year follow-up results of the REDUCE trial

29. Cardiac Troponin Composition Characterization after Non ST-Elevation Myocardial Infarction: Relation with Culprit Artery, Ischemic Time Window, and Severity of Injury

30. Prognostic impact of Vitamin D deficiency in patients with coronary artery disease undergoing percutaneous coronary intervention

31. Benefits with drug-coated balloon as compared to a conventional revascularization strategy for the treatment of coronary and non-coronary arterial disease: a comprehensive meta-analysis of 45 randomized trials

34. Cholecalciferol levels, inflammation and leukocytes parameters: Results from a large single-centre cohort of patients

41. Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial

44. The association of body mass index with long-term clinical outcomes after ticagrelor monotherapy following abbreviated dual antiplatelet therapy in patients undergoing percutaneous coronary intervention : a prespecified sub-analysis of the GLOBAL LEADERS trial

45. Long-Term Performance of the COMBO Dual-Therapy Stent: Results from the REMEDEE Registry

46. Two-year safety evaluation of a biodegradable polymer sirolimus-eluting stent with increased drug elution and polymer absorption kinetics in complex patient and lesion cohort

48. Higher neutrophil-to-lymphocyte ratio (NLR) increases the risk of suboptimal platelet inhibition and major cardiovascular ischemic events among ACS patients receiving dual antiplatelet therapy with ticagrelor

49. Proof of principle of a novel co-pulsating intra-ventricular membrane pump

50. Benefits of short-term or prolonged as compared to standard 1 year DAPT in patients with acute coronary syndrome treated with drug-eluting stents: a meta-analysis of 9 randomized trials

Catalog

Books, media, physical & digital resources